<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04471844</url>
  </required_header>
  <id_info>
    <org_study_id>TRIDENT EF-32</org_study_id>
    <nct_id>NCT04471844</nct_id>
  </id_info>
  <brief_title>Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT &amp; TMZ for the Treatment of Newly Diagnosed GBM</brief_title>
  <acronym>EF-32</acronym>
  <official_title>EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NovoCure GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NovoCure Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the effectiveness and safety of Optune® given concomitantly with radiation therapy&#xD;
      (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation therapy&#xD;
      and temozolomide alone. In both arms, Optune® and maintenance temozolomide are continued&#xD;
      following radiation therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optune® is a medical device that has been approved for the treatment of recurrent and newly&#xD;
      diagnosed glioblastoma (GBM) by the Food and Drug Administration (FDA) in the United States.&#xD;
      Optune® has obtained a CE mark in Europe for recurrent and newly diagnosed GBM.&#xD;
&#xD;
      The current standard of care for GBM includes the addition of Optune® to maintenance&#xD;
      temozolomide (TMZ), following the completion of radiation therapy (RT).&#xD;
&#xD;
      The purpose of the current study is to test if the earlier introduction of Optune®, at the&#xD;
      time of radiation therapy (which is given together with temozolomide), improves clinical&#xD;
      outcomes compared to the standard of care.&#xD;
&#xD;
      The study will randomize 950 subjects equally to one of two treatment arms:&#xD;
&#xD;
        1. Treatment arm I: Patients receive TTFields at 200 kHz to the brain using the Optune®&#xD;
           System together with RT and TMZ, followed by maintenance TMZ concomitant with the&#xD;
           Optune® treatment.&#xD;
&#xD;
        2. Treatment arm II: Patients receive RT and TMZ alone, followed by maintenance TMZ&#xD;
           concomitant with TTFields at 200 kHz to the brain using the Optune®.&#xD;
&#xD;
      All patients are to receive standard RT and TMZ treatment followed by maintenance TMZ&#xD;
      chemotherapy and Optune® according to the current standard of care regimen.&#xD;
&#xD;
      Optune® will continue until second disease progression per RANO Criteria or 24 months (the&#xD;
      earlier of the two) unless any of the treatment discontinuation conditions described under&#xD;
      criteria for patient withdrawal or termination are met.&#xD;
&#xD;
      After surgery or biopsy, subjects that would like to participate will be required to submit&#xD;
      samples of their tumor to a lab for testing. The results of this test will be used for&#xD;
      randomization into the trial.&#xD;
&#xD;
      If the subject is assigned to the treatment group that will start Optune® therapy during&#xD;
      radiation therapy, Optune® therapy will begin within 7 days of enrolling in the study and no&#xD;
      later than the first day of RT and TMZ treatment.&#xD;
&#xD;
      After the initial visit, subjects will continue treatment at home, while pursuing normal&#xD;
      daily routines. Subjects are required to use the device for at least 18 hours a day. Short&#xD;
      breaks in treatment for personal hygiene and other personal needs is allowed. Total usage&#xD;
      time will be recorded and provided to the sponsor.&#xD;
&#xD;
      Subjects will be required to return to the clinic every 4 weeks until study participation&#xD;
      ends. Once every 8 weeks until the tumor potentially returns twice, subjects will have a&#xD;
      contrast MRI of the head and neurological exam performed for the first 6 months of the study&#xD;
      and then at least every three months until a total time period of 24 months.Once every 12&#xD;
      weeks until second disease progression, subjects will also fill out a quality of life&#xD;
      questionnaire.&#xD;
&#xD;
      After the second time the tumor returns, subjects will return to the clinic for one final&#xD;
      visit approximately 30 days after the last treatment with Optune®.&#xD;
&#xD;
      After discontinuing Optune® subjects will be contacted once per month by telephone to answer&#xD;
      basic questions about their health status.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2020</start_date>
  <completion_date type="Anticipated">August 2026</completion_date>
  <primary_completion_date type="Anticipated">August 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomly assigned equally to one of two groups:&#xD;
a. Treatment arm I: Patients receive TTFields at 200 kHz to the brain using the Optune® System together with RT and TMZ, followed by maintenance TMZ concomitant with the Optune® treatment.&#xD;
Treatment arm II: Patients receive RT and TMZ alone, followed by maintenance TMZ concomitant with TTFields at 200 kHz to the brain using the Optune®.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>5 years</time_frame>
    <description>Survival will be measured from the time of randomization until date patient is alive.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival (PFS)</measure>
    <time_frame>5 years</time_frame>
    <description>PFS will be measured from the date of randomization to the date of progression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1- and 2-year survival rates</measure>
    <time_frame>5 years</time_frame>
    <description>The analyses will be performed based on estimated proportions of patients who are on study at 12 and 24 months in both arms of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Radiological response (ORR)</measure>
    <time_frame>5 years</time_frame>
    <description>The analyses will be performed based on the RANO criteria, and comparison between the rates of response.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Next progression-free survival (PFS2)</measure>
    <time_frame>5 years</time_frame>
    <description>PFS2 will be measured from the time of randomization to second tumor progression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival at 6 (PFS6) and 12 months (PFS12)</measure>
    <time_frame>5 years</time_frame>
    <description>The analyses will be estimated proportions of patients who are progression-free at 6 and 12 months in both arms of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity and frequency of adverse events</measure>
    <time_frame>5 years</time_frame>
    <description>The analyses will be performed based on the incidence, severity, frequency of adverse events, and their association with study treatments.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pathological changes in resected GBM tumors following study treatments</measure>
    <time_frame>5 years</time_frame>
    <description>Pathological changes in the tumors and also underwent another surgical resection while on the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life EORTC Questionnaire</measure>
    <time_frame>5 years</time_frame>
    <description>The analyses will be assessed using the EORTC QLQ C-30 questionnaire with BN-20 (brain symptom) supplement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dependence of overall survival on TTFields dose at the tumor</measure>
    <time_frame>5 years</time_frame>
    <description>Examining the dependence of overall survival on TTFields dose delivered to the tumor bed will be performed in both the treatment and control arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The NANO scale</measure>
    <time_frame>5 years</time_frame>
    <description>The Neurological assessment in Neuro-Oncology will be assessed using the NANO scale questionnaire and per RANO criteria.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Glioblastoma Multiforme</condition>
  <arm_group>
    <arm_group_label>Optune® + RT + TMZ for 6 weeks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optune® + RT + TMZ for 6 weeks, followed by Optune® + TMZ until the tumor progresses. Optune treatment is maintained until second disease progression or 24 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT +TMZ for 6 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RT +TMZ for 6 weeks followed by Optune® + TMZ until the tumor progresses. Optune treatment is maintained until second disease progression or 24 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optune®</intervention_name>
    <description>Optune® is a commercial, portable, battery-operated device intended for continuous home use, which delivers TTFields at a frequency of 200kHz to the brain by means of insulated transducer arrays. The Optune® device produces electric forces intended to disrupt cancer cell division.&#xD;
In treatment arm I, the patient starts Optune® concurrently with RT/TMZ for 6 weeks, followed by Optune® + TMZ until second disease progression.&#xD;
In treatment arm II, the patient starts RT/TMZ for 6 weeks, followed by Optune® + TMZ until second disease progression.&#xD;
The study treatment plan will continue for 24 months, if no tumor progression.</description>
    <arm_group_label>Optune® + RT + TMZ for 6 weeks</arm_group_label>
    <arm_group_label>RT +TMZ for 6 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Histologically confirmed diagnosis of GBM according to WHO classification criteria.&#xD;
&#xD;
          2. Age ≥ 22 years in US and Age ≥ 18 years in Ex-US&#xD;
&#xD;
          3. Recovered from maximal debulking surgery, if applicable (gross total resection,&#xD;
             partial resection, and biopsy-only patients are all acceptable)&#xD;
&#xD;
          4. Planned treatment with RT/TMZ followed by TTFields and maintenance TMZ (150-200 mg/m2&#xD;
             daily x 5 d, q28 days)&#xD;
&#xD;
          5. Karnofsky performance status ≥ 70&#xD;
&#xD;
          6. Life expectancy ≥ least 3 months&#xD;
&#xD;
          7. Participants of childbearing age must use highly effective contraception. An effective&#xD;
             method of birth control is defined as one that results in a failure rate of less than&#xD;
             1% per year when used consistently and correctly. The Investigator must approve the&#xD;
             selected method, and may consult with a gynecologist as needed.&#xD;
&#xD;
          8. All patients must understand and voluntarily sign an informed consent document prior&#xD;
             to any study related assessments/procedures being conducted.&#xD;
&#xD;
          9. Stable or decreasing dose of corticosteroids for the last 7 days prior to&#xD;
             randomization, if applicable.&#xD;
&#xD;
         10. Concomitant RT with TMZ treatment planned to start no later than 8 weeks from surgery&#xD;
&#xD;
         11. Women of childbearing potential must have a negative β-HCG pregnancy test documented&#xD;
             within 14 days prior to registration&#xD;
&#xD;
         12. Is able to have MRI with contrast of the brain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Progressive disease (per investigator's assessment)&#xD;
&#xD;
          2. Infratentorial or leptomeningeal disease&#xD;
&#xD;
          3. Participation in another clinical treatment study during the pre-treatment and/or the&#xD;
             treatment phase of the study&#xD;
&#xD;
          4. Pregnancy or breast-feeding.&#xD;
&#xD;
          5. Significant co-morbidities at baseline which would preclude maintenance RT or TMZ&#xD;
             treatment, as determined by the investigator:&#xD;
&#xD;
               1. Thrombocytopenia (platelet count &lt; 100 x 103/μL)&#xD;
&#xD;
               2. Neutropenia (absolute neutrophil count &lt; 1.5 x 103/μL)&#xD;
&#xD;
               3. CTC grade 4 non-hematological Toxicity (except for alopecia, nausea, vomiting)&#xD;
&#xD;
               4. Significant liver function impairment - AST or ALT &gt; 3 times the upper limit of&#xD;
                  normal&#xD;
&#xD;
               5. Total bilirubin &gt; 1.5 x upper limit of normal&#xD;
&#xD;
               6. Significant renal impairment (serum creatinine &gt; 1.7 mg/dL, or &gt; 150 µmol/l)&#xD;
&#xD;
               7. History of any psychiatric condition that might impair patient's ability to&#xD;
                  understand or comply with the requirements of the study or to provide consent&#xD;
&#xD;
          6. Implanted pacemaker, defibrillator, deep brain stimulator, other implanted electronic&#xD;
             devices in the brain, or documented clinically significant arrhythmias.&#xD;
&#xD;
          7. Evidence of increased intracranial pressure (midline shift &gt; 5mm, clinically&#xD;
             significant papilledema, vomiting and nausea or reduced level of consciousness)&#xD;
&#xD;
          8. History of hypersensitivity reaction to TMZ or a history of hypersensitivity to DTIC.&#xD;
&#xD;
          9. Any other cytotoxic or biologic anti-tumor therapy received prior to enrollment will&#xD;
             be considered exclusion.&#xD;
&#xD;
         10. Admitted to an institution by administrative or court order.&#xD;
&#xD;
         11. Known allergies to medical adhesives or hydrogel&#xD;
&#xD;
         12. A skull defect (such as, missing bone with no replacement)&#xD;
&#xD;
         13. Prior radiation treatment to the brain for the treatment of GBM&#xD;
&#xD;
         14. Any serious surgical/post-operative condition that may risk the patient according to&#xD;
             the investigator&#xD;
&#xD;
         15. Standard TTFields exclusion criteria include&#xD;
&#xD;
               1. Active implanted medical devices&#xD;
&#xD;
               2. Bullet fragments&#xD;
&#xD;
               3. Skull defects&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leonardo Lustgarten, MD</last_name>
    <phone>+1 603 206 2337</phone>
    <email>clinicaltrials@novocure.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Doria Kaluza</last_name>
    <phone>+1 603 206 2337</phone>
    <email>clinicaltrials@novocure.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grandview Cancer Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer De Los Santos, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital and Medical Center - Barrow Neurological Institute</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekokobe Fonkem, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic- Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terence Sio, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Arizona Cancer Center</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85719</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Baldasarre Stea, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Highlands Oncology Group</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thaddeus J Beck, MD</last_name>
      <phone>479-587-1700</phone>
      <email>tbeck@hogonc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>City of Hope National Medical Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Portnow, MD</last_name>
      <phone>626-218-3793</phone>
      <email>jportnow@coh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>TRIO - St. Jude Heritage Healthcare/St. Jude Medical Center</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92835</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Park, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego - Moores Cancer Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Piccioni, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norris Comprehensive Cancer Center at USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Ye, MD</last_name>
      <phone>323-865-3052</phone>
      <email>jason.ye@med.usc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars - Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jethro Hu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Providence St. Joseph Medical Center and The Roy and Patricia Disney Family Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>91505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naveed Wagle, MD</last_name>
      <phone>310-829-8265</phone>
      <email>WagleN@jwci.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital - Hoag Cancer Center</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Carrillo, MD</last_name>
      <phone>949-764-4430</phone>
      <email>jose.carrillo@hoag.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph Hospital of Orange</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joscelyn Green</last_name>
      <phone>714-734-6220</phone>
      <email>joscelyn.green@stjoe.org</email>
    </contact>
    <contact_backup>
      <last_name>Rachelle Alquitela</last_name>
      <phone>(714) 734-6200</phone>
      <email>rachelle.alquitela@stjoe.org</email>
    </contact_backup>
    <investigator>
      <last_name>Lars Anker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lars Anker, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California - Irvine/UCI Medical Center</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniela Bota, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford University Cancer Institute</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seema Nagpal, MD</last_name>
      <phone>650-725-8630</phone>
      <email>snagpal@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Seema Nagpal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial Hospital - X-Ray Medical Group Radiation Oncology</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Siavash Jabbari, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicholas Butowski, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Wayne Cancer Institute at St. John's Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Santosh Kesari, MD</last_name>
      <phone>310-582-7437</phone>
      <email>KesariPI@jwci.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Stanford Cancer Institute</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seema Nagpal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado Cancer Center Anschutz</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Denise Damek, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>HCA Research Institute - Blue Sky Neurology - Denver</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Pearlman, MD</last_name>
      <phone>303-806-7423</phone>
      <email>alicia.novak@hcahealthcare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hartford Healthcare Medical Group - Hartford Hospital The Gray Cancer Center</name>
      <address>
        <city>New London</city>
        <state>Connecticut</state>
        <zip>06320</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Daher, MD</last_name>
      <phone>860-696-5169</phone>
      <email>ahmad.daher@hhchealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lynn Cancer Institute, Marcus Neuroscience Institute</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33486</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajeel Chowdhary, MD</last_name>
      <phone>561-955-6400</phone>
      <email>schowdhary@brrh.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health - Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Cavaliere, MD</last_name>
      <phone>904-202-7300</phone>
      <email>robert.cavaliere@bmcjax.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jennifer Peterson, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AdventHealth</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Newton, MD</last_name>
      <phone>407-303-3235</phone>
      <email>susan.coakley@adventhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orlando Health UF Health Cancer Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Avgeropoulos, MD</last_name>
      <phone>321-841-7218</phone>
      <email>Nicholas.Avgeropoulos@OrlandoHealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. Lee Moffitt Cancer Center and Research Institute, Inc</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Yu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Healthcare Brain Tumor Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Dunbar, MD</last_name>
      <phone>404-605-2050</phone>
      <email>erin.dunbar@piedmont.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Emory Clinic - Emory Healthcare - Winship Cancer Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hui-Kuo Shu, MD</last_name>
      <phone>404-778-3473</phone>
      <email>hgshu@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joo Yeon Nam, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parkview Cancer Institute - Fort Wayne Radiation Oncology Associates</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian Chang, MD</last_name>
      <phone>260-266-9100</phone>
      <email>bchang02@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Kansas Cancer Center</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shalina Gupta-Burt, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth</name>
      <address>
        <city>Edgewood</city>
        <state>Kentucky</state>
        <zip>41017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Curry, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Louisville - James Graham Brown Cancer Center</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shiao Woo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norton Cancer Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato LaRocca, MD</last_name>
      <phone>502-394-6350</phone>
      <email>renato.larocca@nortonhealthcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NeuroMedical Center - Mary Bird Cancer Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70810</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jon Olson, MD</last_name>
      <phone>504-336-2667</phone>
      <email>olsonjmd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LSU Health Sciences Center, New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aaron Mammoser, MD</last_name>
      <phone>504-568-6123</phone>
      <email>amammo@lsuhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ochsner Health System</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121-2429</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcus Ware, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maine Medical Partners Neurology - Neurosurgery &amp; Spine Associates</name>
      <address>
        <city>South Portland</city>
        <state>Maine</state>
        <zip>04106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Lu-Emerson, MD</last_name>
      <phone>207-883-1414</phone>
      <email>cluemerson@mmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lawrence Kleinberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brett Theeler, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suriya Jeyapalan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan Comprehensive Cancer Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Larry Junck, MD</last_name>
      <phone>734-232-9039</phone>
      <email>ljunck@umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern Hospital - Givens Brain Tumor Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Trusheim, MD</last_name>
      <phone>612-863-3452</phone>
      <email>john.trusheim@allina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Health Clinics and Surgery Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Neil, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri - Ellis Fischel Cancer Center</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregg Biedermann, MD</last_name>
      <phone>573-884-8264</phone>
      <email>biedermanng@health.missouri.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Health Midwest Ventures Group, Inc - Sarah Cannon HCA Midwest Brain and Spine</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Ansstas, MD</last_name>
      <phone>314-286-0896</phone>
      <email>gansstas@wustl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Amy Chan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>JFK Neuroscience Institute, HMH JFK University Medical Center</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>08820</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Landolfi, MD</last_name>
      <phone>732-321-7010</phone>
      <email>Joseph.Landolfi@hackensackmeridian.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center - John Theurer Cancer Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Goldlust, MD</last_name>
      <phone>551-996-5266</phone>
      <email>samuel.goldlust@hackensackmeridian.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health System Brain Tumor Center</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexis Demopoulos, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NYU Langone - Laura &amp; Issac Perimutter Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Sulman, MD</last_name>
      <phone>646-501-6153</phone>
      <email>erik.sulman@nyulangone.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mount Sinai - Icahn School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adilia Hormigo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian - Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Iwamoto, MD</last_name>
      <phone>212-342-0571</phone>
      <email>fi2146@cumc.columbia.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Wasilewski, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Brain Tumor Program - UNC Lineberger Comprehensive Cancer Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Khagi, MD</last_name>
      <phone>314-229-9909</phone>
      <email>skhagi@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Novant Health Medical Center Huntersville</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Scott L McGinnis, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vidant Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27834</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jasmin Jo, MD</last_name>
      <phone>252-816-2273</phone>
      <email>Jasmin.Jo@vidanthealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Forsyth Medical Center-Novant Health</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Volker Stieber, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Comprehensive Cancer Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Lesser, MD</last_name>
      <phone>336-716-9527</phone>
      <email>glesser@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati Cancer Institute</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyle Wang, MD</last_name>
      <phone>603-244-9889</phone>
      <email>wang2kl@ucmail.uc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Case Western - University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robin Buerki, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The James Cancer Hospital and Solove Research Institute - Arthur G James Cancer Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Piere Giglio, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97339</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jerry Jaboin, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Health System</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anand Mahadevan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Steven Brem, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenyin Shi, MD</last_name>
      <phone>215-955-6702</phone>
      <email>wenyin.shi@jefferson.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegheny Health Network</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zachary Horne, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UPMC Hillman Cancer Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Lieberman, MD</last_name>
      <phone>412-648-6507</phone>
      <email>liebermanf@upmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Toms, MD</last_name>
      <phone>401-793-9175</phone>
      <email>steven.toms@lifespan.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MUSC Radiation Oncology Brain &amp; Spine Tumor Program</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Lindhorst, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCRI - Tennessee Oncology</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Graham, MD</last_name>
      <phone>434-409-7128</phone>
      <email>rmgraham@tnonc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Cancer Center - Germantown</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Ballo, MD</last_name>
      <phone>901-683-0055</phone>
      <email>mballo@westclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>SCRI - Tennessee Oncology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Spigel, MD</last_name>
      <phone>615-524-4016</phone>
      <email>colleen.shaw@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anthony Cmelak, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology Midtown - Austin Brain Tumor Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Brenner, MD</last_name>
      <phone>512-421-4100</phone>
      <email>andrew.brenner@usoncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Charles A. Sammons Cancer Center - Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karen Fink, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Peter Smith Health Network - JPS Cancer Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Mantilla, MD</last_name>
      <phone>817-702-8300</phone>
      <email>emantill@jpshealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ivo Tremont, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UT Health Mischer Neuroscience - Memorial Herman - UT Neurosciences</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jay-Jinguang Zhu, MD</last_name>
      <phone>832-799-7362</phone>
      <email>jay.jiguang.zhu@uth.tmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Antonio Cancer Institute</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Brenner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Medical Center</name>
      <address>
        <city>Temple</city>
        <state>Texas</state>
        <zip>76508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Tann, MD</last_name>
      <phone>254-724-2417</phone>
      <email>anne.tann@bswhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The University of Vermont Medical Center - University of Vermont Cancer Center</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alissa Thomas, MD</last_name>
      <phone>802-656-8982</phone>
      <email>alissa.thomas@uvmhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Massey Cancer Center - VCU Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Timothy Harris, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Swedish Health Services</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kester Phillips, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UW Medical Center - Alvord Brain Tumor Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tresa McGranahan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Virginia University Cancer Institute</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sonikpreet Aulakh, MD</last_name>
      <phone>248-463-8181</phone>
      <email>sonikpreet.aulakh@hsc.wvu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare St Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cecelia Gzell, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Newcastle</name>
      <address>
        <city>Gateshead</city>
        <state>New South Wales</state>
        <zip>2290</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mike Fay, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Hurstville - Centre for radiation oncology Waratah Private Hospital</name>
      <address>
        <city>Hurstville</city>
        <state>New South Wales</state>
        <zip>2220</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrej Bece, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Wesley - Wesley Medical Centre</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4066</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Lowrey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Kurralta Park</name>
      <address>
        <city>Kurralta Park</city>
        <state>South Australia</state>
        <zip>5037</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Potter, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Innsbruck University Hospital</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christian Freyschlag, Prof</last_name>
      <phone>+43 (0)512/504-27284</phone>
      <email>christian.freyschlag@i-med.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kepler University Hospital</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isolde Höllmüller, Dr.</last_name>
      <phone>43 5 7680 87</phone>
      <phone_ext>24212</phone_ext>
      <email>Isolde.Hoellmueller@kepleruniklinikum.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Salzburg</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Greil, Prof</last_name>
      <phone>+43 (0)5 7255-25800</phone>
      <email>r.greil@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Erasme</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier De Witte, Prof</last_name>
      <phone>0032 2 555 3357</phone>
      <email>olivier.de.witte@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Liege - Sart Tilman</name>
      <address>
        <city>Liège</city>
        <zip>B35, 4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Freres, Dr.</last_name>
      <phone>0032 4 242 52 00</phone>
      <email>pfreres@chuliege.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BC Cancer Agency Vancouver Centre</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian Thiessen, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital Cancer Centre</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Garth Nicholas, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Warren Mason, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHUM Centre de Recherche</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah Lapointe, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universite de Sherbrooke - Sherbrooke Centre Hospitalier Universita</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Mathieu, Prof</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Masaryk Memorial Cancer Institute</name>
      <address>
        <city>Brno</city>
        <zip>53</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Radek Lakomý, Dr.</last_name>
      <phone>00420 543 13 2203</phone>
      <email>lakomy@mou.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Plzeň</name>
      <address>
        <city>Pilsen</city>
        <zip>305 99</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimír Přibáň, Prof</last_name>
      <phone>+420777083964</phone>
      <email>pribanv@fnplzen.cz</email>
    </contact>
    <investigator>
      <last_name>Vladimír Přibáň, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <zip>150 30</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Šroubek, Dr.</last_name>
      <phone>00420-603-440-166</phone>
      <email>jan.sroubek@homolka.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de cancérologie de l'Ouest</name>
      <address>
        <city>Angers</city>
        <zip>49055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paule Augereau</last_name>
      <phone>0033 244853722</phone>
      <email>paule.augereau@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pierre Wertheimer Hospital</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francois Ducray, Prof</last_name>
      <phone>0033 (0)4 72 35 78 06</phone>
      <email>francois.ducray@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olivier Chinot, Prof</last_name>
      <phone>0033 (0)4 91 38 55 00</phone>
      <email>olivier.chinot@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Nice</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Veronique Bourg, Prof</last_name>
      <phone>0033 (0)4 92 03 87 69</phone>
      <email>bourg.v@chu-nice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pitié-Salpêtrière University Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Agusti Alentron, Prof</last_name>
      <phone>0033 1 42 16 03 81</phone>
      <email>agusti.alentorn@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institute Cancer Westerly Nantes</name>
      <address>
        <city>Saint Herblain</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Sebastien Frenel, Prof</last_name>
      <phone>0033 240679714</phone>
      <email>carole.gourmelon@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>IUCT Oncopole - CLCC Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Moyal</last_name>
      <phone>0033 5 82 74 16 07</phone>
      <email>Moyal.Elizabeth@iuct-oncopole.fr</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Moyal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Institute Cancer Toulouse Oncopole</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Moyal, Prof</last_name>
      <phone>0033 5 82 74 16 07</phone>
      <email>Moyal.Elizabeth@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gustave Roussy Institute</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frederic Dhermain, Prof</last_name>
      <phone>0033 (0)1 42 11 62 20</phone>
      <email>frederic.dhermain@gustaveroussy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Kaul, Prof</last_name>
      <phone>0049 30 450 527 112</phone>
      <email>david.kaul@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Glas, Prof</last_name>
      <phone>0049 201 723 2461</phone>
      <email>martin.glas@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Freiburg</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anca-Ligia Grosu, Prof</last_name>
      <phone>0049-761-270-94610</phone>
      <email>anca.grosu@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jurgen Debus, Prof</last_name>
      <phone>0049 6221 56-8200</phone>
      <email>juergen.debus@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clemens Seidel, Prof</last_name>
      <phone>0049 3 41 9 71 2300</phone>
    </contact>
    <contact_backup>
      <last_name>clemens.seidel@medizin.uni-leipzig.de</last_name>
      <phone>0049 3 41 9 71 8471</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Rechts der Isar Hospital</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan Stefan Kirschke, Prof</last_name>
      <phone>0049 89 4140 5654</phone>
      <email>jan.kirschke@tum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ghazaleh Tabatabai, Prof</last_name>
      <phone>0049 7071 29-85018</phone>
      <email>ghazaleh.tabatabai@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>3109601</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tzahala Tzuk-Shina, Dr.</last_name>
      <phone>00(972) 5020-63500</phone>
      <email>t_tzuk@rambam.health.gov.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center - Ein Kerem</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexander Lossos, Dr.</last_name>
      <phone>00(972)508946874</phone>
      <email>alos@hadassah.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center</name>
      <address>
        <city>Petah Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shlomit Yust, Dr.</last_name>
      <phone>00(972) 3937-8077</phone>
      <email>shlomit2@clalit.org.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Ramat Gan</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leor Zach, Dr.</last_name>
      <phone>00(972) 5266-67153</phone>
      <email>leor.zach@sheba.health.gov.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rachel Grossman, Dr.</last_name>
      <phone>00(972) 5273-60004</phone>
      <email>rachelgr@tlvmc.gov.il</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lausanne University Hospital</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andreas Hottinger, Dr.</last_name>
      <phone>0041 21 314 46 90</phone>
      <email>Andreas.Hottinger@chuv.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Roth, Dr.</last_name>
      <phone>00(41) 4425-55511</phone>
      <email>patrick.roth@usz.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>France</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2020</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GBM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioblastoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

